Portfolio Company · Operating Co.
CV

Cagent Vascular

CurrentHealthcare
Cagent Vascular
a portfolio company of
US Venture Partners
Status on record: Current
PE Firm Index

Who owns Cagent Vascular?

Cagent Vascular is listed as a current portfolio company of US Venture Partners on US Venture Partners' own portfolio page.

From the company's website

Cagent Vascular pioneers Serration Remodeling Therapy (SRT) creating controlled lines of weakness to release the internal elastic lamina, reducing recoil and increasing luminal gain in PAD angioplasty.

Source: cagentvascular.com, read November 2026

Company Snapshot

Cagent Vascular is a Healthcare company. Its owner on record, US Venture Partners, is a firm. US Venture Partners lists 144 companies in the index, 9 of them in Healthcare.

Parent PE firmUS Venture Partners
Ownership statusCurrent
WebsiteVisit ↗

About the owner

Questions about Cagent Vascular

Who owns Cagent Vascular?

Cagent Vascular is listed as a current portfolio company of US Venture Partners on US Venture Partners' own portfolio page.

What sector is Cagent Vascular in?

Cagent Vascular is in Healthcare. Classified from the company's own description.

What else does US Venture Partners own in Healthcare?

US Venture Partners lists 8 other Healthcare companies in the index, including AImbient, Carlsmed, Carrot, HighLife Medical and Luminopia.

What is Cagent Vascular's website?

Cagent Vascular's website is https://cagentvascular.com/.

Sources

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Cagent Vascular and does not provide investment advice.

Other portfolio companies of US Venture Partners

6 of 143 shown

See the full US Venture Partners portfolio.

Other Healthcare companies held by US Venture Partners

Other Healthcare portfolio companies

Browse PE-backed companies.